A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis Pigmentosa

NCT00458575 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped Internal Business Decision

Conditions

Retinitis Pigmentosa

Interventions

DRUG: CNTO 2476

Sponsor

Centocor, Inc.